The effects of COVID-19 lockdown on glycaemic control and lipid profile in patients with type 2 diabetes: a systematic review and meta-analysis
Ojo, Omorogieva ORCID: 0000-0003-0071-3652, Wang, Xiaohua, Ojo, Osarhumwese, Orjih, Edith, Pavithran, Nivedita, Adegboye, Amanda ORCID: 0000-0003-2780-0350, Feng, Qian-Qian and Mccrone, Paul ORCID: 0000-0001-7001-4502 (2022) The effects of COVID-19 lockdown on glycaemic control and lipid profile in patients with type 2 diabetes: a systematic review and meta-analysis. International Journal of Environmental Research and Public Health, 19 (3):1095. ISSN 1660-4601 (Online) (doi:https://doi.org/10.3390/ijerph19031095)
|
PDF (Author's published manuscript)
34825_OJO_The_effects_of_COVID_19_lockdown_on_glycaemic_control.pdf - Published Version Available under License Creative Commons Attribution. Download (2MB) | Preview |
Abstract
The impact of the COVID-19 lockdown on glycaemic control and other metabolic parameters in patients with type 2 diabetes is still evolving. Aim: This systematic review and meta-analysis aims to examine the effects of COVID-19 lockdown on glycaemic control and lipid profile in patients with type 2 diabetes. Methods: The PRISMA framework was the method used to conduct the systematic review and meta-analysis, and the search strategy was based on the population, intervention, control and outcome (PICO) model. The Health Sciences Research databases was accessed via EBSCO-host, and EMBASE were searched for relevant articles. Searches were conducted from inception of the databases until 17 September 2021. Results: The results identified three distinct areas: glycaemic control, lipid parameters and body mass index. It was found that COVID-19 lockdown led to a significant (p < 0.01) increase in the levels of glycated haemoglobin (%) compared with pre-COVID group (gp) with a mean difference of 0.34 (95% CI: 0.30, 0.38). Eleven studies contributed to the data for glycated haemoglobin analysis with a total of 16,895 participants (post-COVID-19 lockdown gp, n = 8417; pre-COVID gp, n = 8478). The meta-analysis of fasting plasma glucose (mg/dL) also showed a significant (p < 0.05) increase in levels of post-COVID-19 lockdown gp compared with pre-COVID gp, with a mean difference of 7.19 (95% CI: 5.28, 9.10). Six studies contributed to fasting plasma glucose analysis involving a total of 2327 participants (post-COVID-19 lockdown, n = 1159; pre-COVID gp, n = 1168). The body mass index (BMI) (kg/m2) analysis also demonstrated that post-COVID-19 lockdown gp had a significantly (p < 0.05) higher BMI than the pre-COVID gp with a mean difference of 1.13 (95% CI: 0.99; 1.28), involving six studies and a total of 2363 participants (post-COVID-19 lockdown gp, n = 1186; pre-COVID gp, n = 1177). There were significantly (p < 0.05) lower levels of total cholesterol (mmol/L), triglyceride (mmol/L) and LDL cholesterol (mmol/L), and higher levels of HDL cholesterol (mg/dL) in the post-COVID-19 lockdown gp compared with pre-COVID gp, although these results were not consistent following sensitivity analysis. Conclusion: The findings of the systematic review and meta-analysis have demonstrated that COVID-19 lockdown resulted in a significant increase (p < 0.05) in the levels of glycated haemoglobin, fasting glucose and body mass index in patients with type 2 diabetes. In contrast, the effect of the lockdown on lipid parameters, including total cholesterol, triglycerides, LDL and HDL cholesterol was not consistent.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | type 2 diabetes; COVID-19; COVID-19 lockdown; coronavirus disease-2019; SARS-CoV-2; glycated haemoglobin; lipid parameters; body mass index |
Subjects: | Q Science > QR Microbiology > QR180 Immunology Q Science > QR Microbiology > QR355 Virology R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine |
Faculty / School / Research Centre / Research Group: | Faculty of Education, Health & Human Sciences Faculty of Education, Health & Human Sciences > Institute for Lifecourse Development Faculty of Education, Health & Human Sciences > Institute for Lifecourse Development > Centre for Chronic Illness and Ageing Faculty of Education, Health & Human Sciences > School of Health Sciences (HEA) |
Related URLs: | |
Last Modified: | 21 Jan 2022 11:28 |
URI: | http://gala.gre.ac.uk/id/eprint/34825 |
Actions (login required)
View Item |
Downloads
Downloads per month over past year